Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Parallel-group, Vehicle-controlled, Randomized, Double-blind Study of the Efficacy and Safety of Product 49778 and Product 10156 in Subjects With Seborrheic Dermatitis

NCT01703793 is registered in ClinicalTrials.gov with Medicis Global Service Corporation as lead sponsor.

NCT NCT01703793
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01703793 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Parallel-group, Vehicle-controlled, Randomized, Double-blind Study of the Efficacy and Safety of Product 49778 and Product 10156 in Subjects With Seborrheic Dermatitis
Lead sponsor
Medicis Global Service Corporation
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2012
Completion date
January 31, 2013
Enrollment
240 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

seborrheic dermatitis